Further, we used a KM plotter to analyze overall survival of patients based on TRPV2 expression and observed that lung cancer patients with higher expression of TRPV2 has a significantly better overall survival (p = 4.3 × 10−6) compared to patients with low TRPV2 expression (Figure 6B) [22]. This evidence concerns the gene TRPV2 and lung cancer.